Other investigators have now replicated our finding that cardiac SGLT1 expression is increased in a HFD-streptozotocin (STZ) mouse model of type 2 diabetes in vivo [42] and that high glucose increases SGLT1 expression in cardiomyocytes in vitro [11]. Here, SLC5A1 is linked to type 2 diabetes mellitus.